Vivoverse Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $600K

  • Investors
  • 7

Vivoverse General Information

Description

Operator of AI-powered biological screening platforms intended to support drug discovery, toxicology testing, and chemical safety assessment. The company offers microfluidics, automated 3D imaging, and artificial intelligence technologies for whole-organism phenotypic analysis using C. elegans, enabling pharmaceutical companies, biotechnology firms, and research institutions to conduct preclinical testing and toxicity assessments while reducing reliance on traditional animal studies.

Contact Information

Formerly Known As
Newormics
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3303 Northland Drive
  • Suite 308
  • Austin, TX 78731
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Services
Drug Delivery
Other Healthcare Technology Systems
Corporate Office
  • 3303 Northland Drive
  • Suite 308
  • Austin, TX 78731
  • United States

Vivoverse Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivoverse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 17-Dec-2024 $600K Completed Generating Revenue
9. Grant 05-Aug-2023 Completed Generating Revenue
8. Grant 15-Jul-2021 Completed Generating Revenue
7. Grant 01-Jul-2020 Completed Generating Revenue
6. Grant 01-Apr-2019 Completed Generating Revenue
5. Accelerator/Incubator 29-Oct-2018 Completed Generating Revenue
4. Grant 14-Sep-2018 Completed Generating Revenue
3. Accelerator/Incubator 21-Feb-2018 Completed Generating Revenue
2. Accelerator/Incubator 11-Sep-2017 Completed Generating Revenue
1. Grant 18-Apr-2017 $31K Completed Generating Revenue
To view Vivoverse’s complete valuation and funding history, request access »

Vivoverse Patents

Vivoverse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4690102-A1 Method and compositions for analyzing toxicity in organisms Pending 24-Mar-2023
US-20260266805-A1 Method and compositions for analyzing toxicity in organisms Pending 24-Mar-2023
WO-2024206236-A1 Method and compositions for analyzing toxicity in organisms Inactive 24-Mar-2023 G01N15/1433

Vivoverse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivoverse Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Environmental Health Sciences Government
ACC Bioscience Incubator Accelerator/Incubator
U.S. Department of Health and Human Services Government
MassChallenge Accelerator/Incubator
Texas Venture Labs University Minority
You’re viewing 5 of 7 investors. Get the full list »

Vivoverse FAQs

  • When was Vivoverse founded?

    Vivoverse was founded in 2016.

  • Where is Vivoverse headquartered?

    Vivoverse is headquartered in Austin, TX.

  • What is the size of Vivoverse?

    Vivoverse has 10 total employees.

  • What industry is Vivoverse in?

    Vivoverse’s primary industry is Other Devices and Supplies.

  • Is Vivoverse a private or public company?

    Vivoverse is a Private company.

  • What is Vivoverse’s current revenue?

    The current revenue for Vivoverse is .

  • Who are Vivoverse’s investors?

    National Institute of Environmental Health Sciences, ACC Bioscience Incubator, U.S. Department of Health and Human Services, MassChallenge, and Texas Venture Labs are 5 of 7 investors who have invested in Vivoverse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process